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To expand the knowledge about the consecutive expression of genes involved in the immune system development in preterm
neonates and to verify if the environment changes the gene expression after birth we conducted a prospective study that included
three cohorts: (A) extremely (gestational age (GA): 23–26 weeks; 𝑛 = 41), (B) very (GA: 27–29 weeks; 𝑛 = 39), and (C) moderately
preterm infants (GA: 30–32 weeks; 𝑛 = 33). Blood samples were drawn from the study participants on the 5th and 28th day of
life (DOL). The mRNA samples were evaluated for gene expression with the use of GeneChip Human Gene 1.0ST microarrays.
Differential expression analysis revealed small subsets of genes that presented positive or negative monotone trends in both the
5th (138 genes) and 28th DOL (308 genes) in the three subgroups of patients. Based on pathway enrichment analysis, we found
that most of the pathways that revealed a positive monotone trend were involved in host immunity. The most significantly GA
dependent pathways were T-cell receptor signaling pathway and intestinal immune network for IgA production. Overall 4431
genes were differentially expressed between the 5th and 28th DOL. Despite differences in gestational age, patients with the same
postconceptional age have a very similar expression of genes.
1. Introduction
According to the current statistics, invasive neonatal infec-
tions are responsible for about 36% of the estimated 4million
neonatal deaths annually [1]. Survivors of neonatal sepsis
have an increased risk of prolonged hospital stay, adverse
neurodevelopmental sequelae, and bronchopulmonary dys-
plasia [2, 3]. The prevalence of neonatal sepsis is inversely
correlated with gestational age and birth weight; therefore,
infants born prematurely are particularly highly prone to
developing infection [4]. One of themajor causes of increased
incidence of sepsis in premature neonates is the immaturity
of their immune system [5].
The development of the fetal immune system begins at
4.5–6 weeks of gestation. Throughout gestation two major
systems of fetus defense gradually develop: the nonspecific
innate immunemechanism and the adaptive immune system
[6]. Mechanisms of innate immunity operate effectively
without prior exposure to a microorganism or its antigens.
Adaptive immune response is relatively immature at birth
due to limitations of exposure to antigens in utero and due
to the impaired functions of B and T cells. Therefore, the
protection of the neonate against infection mainly depends
upon passively acquired antibodies transferred from the
mother and components of the innate immune system [7].
The ontogenesis of the immune system correlates with
the developmental age of the fetus, but little is known
when each of the respective aspects of the immune system
matures normally in utero and what the consequences of the
premature birth on these processes are.
It is known from studies conducted so far that the
premature neonates show both qualitative and quantitative
deficits in comparisonwith an adult or term neonate immune
response.These studies were based on quantitative evaluation
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of the elements (cells, receptors) [8] of the immune system
or comparison of their function. There are also studies
evaluating the expression of individual genes involved in the
development of the immune system in infants with variable
degrees of prematurity [9].
The introduction of themicroarray technique into clinical
studies was one of themost important turning points respon-
sible for the dramatic progress in the field of human genetics
during the last decade.
The aim of the study was to evaluate the consecutive
expressions of genes involved in the immune system devel-
opment in preterm neonates and to verify if the environment
changes the gene expression after birth.
2. Methods
A prospective study was conducted between September 1,
2008, and November 30, 2010. The entry criteria were (a)
preterm birth <32 weeks gestational age, (b) birth weight
≤1500 g, and (c) the need for respiratory support. All patients
were outborn in local hospitals and transported to the Polish-
American Children’s Hospital, which is a tertiary care unit for
the region.
The majority of patients are referred from first-level
neonatal care hospitals, which provide mainly for rural areas.
Detailed perinatal history (birth weight, gestational age, and
Apgar score at 1 and 5 minutes after birth) and history of
treatment in the referral hospital (mechanical ventilation,
oxygen therapy, surfactant treatment, and diagnoses) were
taken on admission. Maternal fever/infection was used as
surrogate for “clinical diagnosis of chorioamnionitis.”Data on
histological chorioamnionitis were unavailable inmost cases.
Ureaplasma infectionwas defined as positive tracheal aspirate
culture forUreaplasma urealythicum.The studywas approved
by the Ethics Committee of the Jagiellonian University,
Faculty of Medicine (KBET 27/B/2007). Written informed
consent was obtained from the parents of all participants
involved in the study.
2.1. Characteristics of the Studied Group. One hundred and
twenty newborns were included in the study. The mean birth
weight was 1029 g (SD: 290), and themean gestational agewas
27.8 weeks (SD: 2.5). The majority of the pregnancies were
terminated by abrupt deliveries. Seven newborns died before
the end of the first month of life; therefore, 113 children were
included in the final analysis.
Forty-one infants were included in the extremely preterm
cohort, 39 infants in the very preterm cohort, and 33 infants
in the moderately preterm cohort.The clinical characteristics
of the studied cohorts were presented in Table 1.
2.2. Microarray Analysis. After obtaining written informed
consent from the parents, blood samples (0.3mL) were
drawn from all the study participants on the 5th and 28th
day of life (DOL) for the assessment of whole genome
expression in peripheral blood leukocytes. Subsequently,
Ficoll isopaque gradient centrifugation (30min, 2100 rpm,
RT), two times wash in 1x PBS (12min, 1600 rpm, 40∘C),
and finally RiboPure Blood Kit (Ambion, Life Technologies,
Carlsbad, USA) were used for total RNA extraction. RNA
concentration was measured with the use of NanoDrop
Spectrophotometer (NanoDrop ND-1000; Thermoscientific,
Waltham, USA), and RNA quality was determined by 2100
Bioanalyzer (Agilent, Santa Clara, USA).
100 ng of total RNA was used for the single microar-
ray experiment. GeneChip Human Gene 1.0 ST Arrays
(Affymetrix, Santa Clara, USA) were used. Whole transcript
microarray experiment was performed. Details of microarray
experiment were published previously [10].
2.3. Real-Time PCR Validation. To validate the results
obtained by the microarray analysis real-time PCR technique
was used. A total of 30 cDNA samples remaining after
microarray analysis (30 patients) were used for the validation
procedure. Samples were randomly selected from the studied
groups.
From each sample 100 ng of cDNAwas used for the single
TaqMan Gene Expression Assay, and the expression level of
14 randomly selected genes was determined. Amplification
reaction was performed with the use of TaqMan Universal
PCR Master Mix and appropriate TaqMan probes (Life
Technologies, Carlsbad, USA). Each sample was analyzed in
duplicate.
Average between the expressions of endogenous controls
(housekeeping genes: GAPDH and Actin-B) was used for
determination of the relative expression levels with the use
of ΔΔCt calculation.
Following TaqMan Gene Expression Assays were used:
Hs00900055 m1 (VEGF gene), Hs00952786 m1 (AK5 gene),
Hs00217864 m1 (OLAH gene), Hs01030384 m1 (ILR2 gene),
Hs00187022 m1 (ADAM23 gene), Hs00736937 m1 (DAA-
M2 gene), Hs00360669 m1 (CD177 gene), Hs0025533-
8 m1 (KLRC4 gene), Hs00171191 m1 (FBN1 gene), Hs0-
0539582 s1 (LRRN3 gene), Hs00196254 m1 (NELL2 gene),
Hs00924296 m1 (MPO gene), Hs00541549 m1 (ABCA13
gene), Hs00197437 m1 (OLFM4 gene), GAPDH (Hs0275-
8991 g1), and Actin-B (Hs99999903 m1) (Life Technologies,
Carlsbad, USA).
2.4. Predefined Comparisons. Based on gestational age the
studied group was divided into three cohorts: (a) extremely
preterm infants (born below 27 weeks of gestation), (b) very
preterm infants (born between 27 and 29 weeks of gestation),
and (c) moderately preterm infants—born between 30 and
32 weeks of gestation. Gene expression profile was compared
between the cohorts on the 5th and 28th DOL. Moreover,
the changes between expression values between 5th and 28th
DOL of whole study group were analyzed, too. The final
step of analysis included comparison between the results of
gene expression recorded on the 28th DOL in the group of
extremely preterm infants and the results of gene expression
recorded on the 5thDOL in the group of very preterm infants.
The last comparison provided opportunity to compare both
groups in the similar postmenstrual age.
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Table 1: Comparison of selected demographic data in the studied cohorts.
Extremely preterm
(23–26 weeks)
(𝑛 = 41)
Very preterm
(27–29 weeks)
(𝑛 = 39)
Moderately preterm
(30–32 weeks)
(𝑛 = 33)
𝑃
Birth weight, g (𝑥 ± SD) 727 ± 124 1149 ± 207 1245 ± 211 <0.001a
Gestational age (weeks) (𝑥 ± SD) 25.0 ± 1.1 28.2 ± 0.8 30.7 ± 0.8 <0.001a
Male gender 24 (58%) 20 (51%) 17 (52%) 0.76b
Vaginal delivery/Cesarean section 20/21 15/24 8/25 0.01b
Multiple pregnancy 4 (10%) 8 (20%) 6 (18%) 0.56b
Small-for-gestational-age infant 4 (10%) 1 (2%) 5 (15%) 0.1b
Maternal hypertension 8 (19%) 7 (18%) 2 (8%) 0.74b
Maternal diabetes 3 (7%) 2 (5%) 0 0.79b
Maternal fever/infection prior to delivery 5 (12%) 6 (15%) 4 (13%) 0.8b
1st minute Apgar score (Me; 25–75th percentile) 2 (1–4) 5 (4–6) 5 (2–6) 0.01c
5th minute Apgar score (Me; 25–75th percentile) 6 (4–6) 7 (6-7) 7 (6–8) 0.001c
Delivery room intubation 28 (69%) 16 (40%) 11 (33%) 0.01b
Surfactant therapy 33 (81%) 29 (73%) 14 (43%) 0.003b
Initial a/A ratio 0.31 ± 0.2 0.25 ± 0.13 0.44 ± 0.25 0.01a
Prenatal steroids 10 (25%) 12 (29%) 22 (66%) 0.01b
Ureaplasma infection 12 (29%) 8 (21%) 6 (18%) 0.28b
Pharmacological closure of patent ductus
arteriosus 22 (54%) 23 (59%) 11 (33%) 0.08
b
Surgical closure of patent ductus arteriosus 18 (44%) 4 (10%) 2 (6%) <0.001b
Length of mechanical ventilation
(Me; 25–75th percentile) 42 (25–52) 3 (1–10) 2 (0–6) <0.001
c
Bronchopulmonary dysplasia 40 (98%) 24 (62%) 6 (18%) <0.001b
a
𝑃 value for one-way analysis of variance.
b
𝑃 value for chi-square test.
c
𝑃 value for Kruskal-Wallis analysis of variance.
2.5. Statistical Analysis. Basic demographic data were com-
pared using the one-way analysis of variance or Kruskal-
Wallis analysis of variance as appropriate. Qualitative values
were compared using the chi-square test.
Neonatal data used for the study was recorded daily
during hospitalization in NICU in a prospective manner and
stored in computer databases. For the purpose of the study
the following data was used: sex, birth weight, gestational
age, intrauterine growth parameters, Apgar score, incidence
of preeclampsia, maternal diabetes, preterm rupture of mem-
branes, chorioamnionitis, delivery type, delivery room man-
agement, presence of respiratory distress syndrome (RDS),
length of mechanical ventilation, surfactant administration,
use of ibuprofen for patent ductus arteriosus (PDA), PDA
ligation, early- and late-onset septic episodes, ureaplasma
infection, prevalence of intraventricular hemorrhage (IVH),
periventricular leukomalacia (PVL), weight gain during
NICU stay, and length of hospitalization. The microarray
data were preprocessed using the R/Bioconductor package
aroma.affymetrix [11, 12]. For normalization we used robust
multiarray average (RMA) [13]. Quality control was per-
formed by investigating principal component analysis (PCA),
relative log expression (RLE), and normalized unscaled stan-
dard error (NUSE) plots. None of the arrays were discarded
due to poor quality [14].
Moderated t-tests were performed to detect the probes
that were differentially expressed between groups, using the
limma package in the R statistical software [15]. For the
three categories of gestational age we used Spearman’s rho
statistic to test whether there was a monotonic trend in gene
expression between the categories [16].
Multiple testing corrections, using the Benjamini-
Hochberg procedure, were applied to control the false
discovery rate (FDR) [17]. If a probe set had a corrected for
multiple comparison 𝑃 value less than 0.01, it was declared
significantly differentially expressed.
DAVID annotation tools were used to explore which
predefined gene sets were significantly enriched in one group
compared to another [18]. The KEGG (Kyoto Encyclopedia of
Genes and Genomes; http://www.genome.jp/kegg/) pathways
were selected for analysis. Genes differentially expressed
between the groups with 𝑃 values adjusted for multiple
testing below 0.01 were used as input for pathway enrichment
analysis in DAVID.
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Table 2: Summary of the number of differentially expressed genes between the studied groups.
Comparison
𝑃 < 0.01 adjusted for
multiple comparison
𝑃 < 0.01
𝑃 < 0.01;
fold change >1.5
5th DOL
Genes presented a positive monotone trend
(expression in extremely preterm is lower than
that in very preterm; expression in very preterm is
lower than that in moderately preterm)
56
Genes presented a negative monotone trend 82
28th DOL Genes presented a positive monotone trend 253
Genes presented a negative monotone trend 55
5th DOL versus 28th DOL
(paired 𝑡-test)
Genes whose expressions were significantly
higher on the 28th DOL compared to those on the
5th DOL
1522 150
Genes whose expressions were significantly lower
on the 28th DOL compared to those on the 5th
DOL
2909 337
Extremely preterm infants
measurement on the 28th
DOL versus very preterm
infants measurements on the
5th DOL
Genes whose expressions were significantly
higher in the group of extremely preterm infants
compared to those in the group of very preterm
infants
176 29
Genes whose expressions were significantly lower
in the group of extremely preterm infants
compared to those in the group of very preterm
infants
186 27
The mean fold change values representing differences in
expression between the groups with regard to each of the
14 genes selected for validation were compared between the
microarray and the TaqMan Gene Expression experiments.
Student’s t-test was used for evaluating the statistical signifi-
cance of observed differences between gene expressions.
All data were collected and analyzed in the adherence
to the Minimal Information about a Microarray Experi-
ment guidelines. All primary microarray data were submit-
ted to GEO public repository and are accessible through
GEO Series accession number GSE32472 (http://www.ncbi
.nlm.nih.gov/geo/query/acc.cgi?acc=GSE32472).
3. Results
3.1. Whole Genome Expression. One hundred and thirty-
eight genes presented amonotone trend on the 5th and 308 on
the 28th day of life. A summary of the number of differentially
expressed genes between the groups is presented in Table 2.
4431 genes were differentially expressed between 5th and
28th DOL (paired t-test), including 1522 genes whose expres-
sion increased with time and 2909 genes whose expression
decreased with time. The difference in expression measured
as a fold change ranged between 1.0 and 1.5 in the majority
of genes. Only 487 genes have shown the difference in
expression greater than 1.5.
When the samples collected on 28th DOL in extremely
preterm infants and on 5th DOL in very preterm infants
were compared, the expressions of 176 genes were signifi-
cantly higher in the group of extremely preterm infants and
the expressions of 186 gene genes were significantly lower.
The difference in expression measured as a fold change of 56
genes was greater than 1.5.
3.2. Pathway Enrichment Analysis. Differentially expressed
genes (with 𝑃 values adjusted for multiple testing below
0.01) were used as input for pathway enrichment analysis in
DAVID.
A summary of the analysis is presented in Table 3. There
was no pathway upregulated in the group of extremely
preterm infants neither on the 5th DOL nor 28th DOL.
However, 4 pathways were downregulated on 5th DOL and
5 pathways were downregulated on 28th DOL in the group
of extremely preterm infants. Among above-mentioned path-
ways, three were downregulated in both time points: T-cell
receptor signaling, hematopoietic cell lineage, and intestinal
immune network for IgA production pathways.
The differentially expressed genes between 5th and 28th
DOL studies belonged to 21 pathways; 12 pathways were
upregulated and 9 pathways were downregulated. Among 12
pathways whose expression was higher on 28th DOL than on
5th DOL were T-cell receptor signaling, hematopoietic cell
lineage, and intestinal immune network for IgA production
pathways.
When the expression of genes on the 28th DOL in
the group of extremely preterm infants was compared to
expression on the 5th DOL in the group of very preterm
infants, only 3 pathways were differentially upregulated.
Surprisingly, there was no pathway downregulated.
3.3. Real-Time PCR Validation. The validation procedure
did not reveal significant differences between the results
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Table 3: Summary of the pathway analysis for the differentially expressed genes between the groups. Pathways with FDR value less than 15%
are shown.
Input to pathway analysis Pathway name FDR (%)
Genes presented a positive monotone trend on the 5th
DOL, adjusted for multiple comparison 𝑃 < 0.01
(expression in extremely preterm is lower than that in
very preterm; expression in very preterm is lower than
that in moderately preterm)
T-cell receptor signaling pathway
Cell adhesion molecules (CAMs)
Hematopoietic cell lineage
Intestinal immune network for IgA production
0.6
1.3
3.7
12.5
Genes presented a negative monotone trend on the 5th
DOL, adjusted for multiple comparison 𝑃 < 0.01 No pathway
Genes presented a positive monotone trend on the 28th
DOL, adjusted for multiple comparison 𝑃 < 0.01
Primary immunodeficiency
T-cell receptor signaling pathway
Hematopoietic cell lineage
Intestinal immune network for IgA production
Cytokine-cytokine receptor interaction
0.01
0.02
1.3
4.9
10.5
Genes presented a negative monotone trend on the 28th
DOL, adjusted for multiple comparison 𝑃 < 0.01 No pathway
Genes whose expressions were significantly higher on
the 28th DOL compared to those on the 5th DOL
(paired 𝑡-test, 𝑃 < 0.01; fold change > 1.5)
Graft-versus-host disease
Allograft rejection
Antigen processing and presentation
Intestinal immune network for IgA production
Cell adhesion molecules (CAMs)
Primary immunodeficiency
Hematopoietic cell lineage
Natural killer cell-mediated cytotoxicity
Cytokine-cytokine receptor interaction
B-cell receptor signaling pathway
T-cell receptor signaling pathway
Jak-STAT signaling pathway
<0.001
<0.001
<0.001
<0.001
<0.001
0.03
0.04
0.13
0.5
1.8
5.8
6.0
Genes whose expressions were significantly lower on
the 28th DOL compared to those on the 5th DOL
(paired 𝑡-test, 𝑃 < 0.01; fold change > 1.5)
Cell cycle
Regulation of actin cytoskeleton
Fc gamma R-mediated phagocytosis
Glycolysis/gluconeogenesis
Lysosome
Endocytosis
Base excision repair
Leukocyte transendothelial migration
Glutathione metabolism
0.27
1.04
1.09
1.54
3.46
3.50
5.69
7.59
8.30
Genes whose expressions were significantly higher in
the group of extremely preterm infants (measurements
on the 28th DOL) compared to those in the group of
very preterm infants (measurements on the 5th DOL);
𝑃 values adjusted for multiple testing, 𝑃 < 0.01
Graft-versus-host disease
Cytokine-cytokine receptor interaction
Natural killer cell-mediated cytotoxicity
0.01
0.4
2.3
Genes whose expressions were significantly lower in the
group of extremely preterm infants (measurements on
the 28th DOL) compared to those in the group of very
preterm infants (measurements on the 5th DOL);
𝑃 values adjusted for multiple testing, 𝑃 < 0.01
No pathway
obtained with use of microarrays compared to real-time PCR
technique [10].
4. Discussion
The use of microarrays has provided a new opportunity for
studying even 20000 human genes in a single experiment.
The greatest advantage of this method is that it enables the
assessment of a huge number of genetic factors (practically all
human gene expression), while only a small amount of blood
is necessary for testing, which is very important in preterm
neonates.
In this study we assessed the whole genome expression
in a cohort of preterm neonates in the 5th and 28th day of
life. The cohort was subdivided into three groups depending
on the gestational age (extremely preterm, very preterm,
and moderately preterm), as described above. The genomic
expression was compared between these three groups. To our
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knowledge this cohort is the first one designed to assess
the whole genome expression among preterm neonates. The
nature of the study was mainly exploratory.
Differential expression analysis revealed small subsets of
genes that presented positive or negative monotone trends
in both the 5th and 28th DOL in the three subgroups of
patients, depending on the gestational age. On the contrary,
we found a much higher number of genes that revealed
positive or negative monotone trends when we compared
gene expression between the 5th and 28th DOL in the whole
cohort. In this comparison, significantly more genes were
underexpressed in the 28th DOL rather than overexpressed.
Finally we attempted to assess the impact of the extrauterine
environment on genomic expression and compared the group
of extremely preterm newborns on 28th DOL with very
preterm newborns on 5th DOL.The analysis revealed a com-
parable number of genes that were over- and underexpressed.
Using pathway enrichment analysis, which allows us to
identify network expression alterations that may be insignif-
icant on the level of individual genes, we identified pathways
that were differentially regulated with regard to gestational
age. We found that most of the pathways that revealed a
positive monotone trend on both the 5th and 28th DOL
between all three age groups are involved in host immunity.
Similarly we observed a significantly higher expression of
pathways involved in immune response when we compared
patients on 5th and 28th DOL, regardless of the gestational
age. Both analyses revealed a relative increase in T-cell
receptor signaling pathway and intestinal immune network
for IgA production.
4.1. T-Cell Receptor Signaling Pathway. Theneonatal immune
system, both innate and adaptive, bears features of functional
immaturity and therefore significantly contributes to neona-
tal morbidity and mortality [6, 19, 20]. The innate immune
system is the first line of defense against invading pathogens
that include numerousmechanisms such as skin andmucosal
barriers, cellular network (neutrophils, monocytes, antigen-
presenting cells, and natural killer cells), toll-like receptors
(TLR), and humoral factors (e.g., complement). It can operate
sufficiently without previous exposure to antigens in term
newborns, and due to the limited fetal exposure to antigens
it is a major protective mechanism for the newborn [6, 21].
The major innate immune system involves TLRs, which are
dedicated to recognize PAMP (pathogen associated molec-
ular pattern). However, it has been shown that the innate
immune system reveals features of immaturity in prematurely
born newborns. Recent study by Tissie`res et al. [5] proves that
the level of cytokines involved in innate immune response is
lower in preterm than in term newborns and, interestingly,
that this deficiency could be reversed by treatment with
interferon-𝛾.
Conversely, the adaptive immune response requires anti-
gen exposure and develops gradually after birth. In new-
borns, cytokine production in response to stimuli exhibits
polarization withTh-1 response downregulation [22, 23].Th-
1 cytokine production impairment has been presupposed
to be involved in decreased defensive mechanisms against
viral pathogens, including HSV [24], CMV [25], and other
intracellular pathogens like Listeria spp., Toxoplasma [26],
or Mycobacterium tuberculosis, particularly in preterm new-
borns.
In the current study we demonstrated for the first time
a coherent trend of increasing expression of genes involved
in T-cell receptor signaling with increasing gestational and
chronological age. The functional changes of the developing
immune system, including regulatory T-cell (Treg) matu-
ration [27], monocyte stimulation ability [28], complement
system [29], or T-cell response to Toll-like receptor ligands
(for example, LPS) [30], have been described in previously
published papers. Our results might reflect dynamic matura-
tional changes involved in the development of fetal adaptive
immunity mechanisms that could be responsible for the
increased risk of serious infections andmortality in extremely
premature newborns.
4.2. Intestinal Immune Network for IgA Production. Intesti-
nal immunity consists of two major components—innate
defenses (gastric acid, protolithic enzymes, intestinal mucin,
permeability, defensins, cathelicydins, and lectins (REG3
𝛾
)
[31] and active immunity (T and B lymphocytes, secretory
IgA). After induction ofmucosal B cells in the Peyer’s patches,
B cells circulate through the bloodstream to the mesenteric
lymph node and enter the intestinal submucosa, where they
start to produce IgA, which is subsequently exported by
means of transcytosis across the intestinal membranes [32].
IgA protects against bacterial, parasitic, and viral mucosal
pathogens by neutralizing toxins and blocking the adherence
and penetration of microorganisms. It can also induce effec-
tor immune responses and therefore maintain the intestinal
microflora and immune homeostasis [33–35]. In our studywe
demonstrated that the expression of genes from the intestinal
immune network for IgA production increases with post-
conceptional age. This fact may be connected with gradually
increasing host defenses in premature babies against toxins
and microorganisms.
Apart from genetic predisposition, disruption of the
intestinal barrier secondary to hypoxic mucosal injury, bac-
terial colonization and formula feeding, immaturity of the
gut mucosal immunity, and a relative deficiency of sIgA in
the premature neonate have been implicated as a potential
risk factor for NEC [36, 37]. Secretory IgA (sIgA) has
been recognized as a critically important component of
mucosal defence and some of the protective effects of human
colostrum and milk against NEC have been attributed to
its sIgA content [36]. According to Anderson and Kliegman
[38], supplementation of enteral immunoglobulin rich in
IgA can reduce the risk of NEC. We can speculate that
the increasing gene expression of the intestinal immune
network for IgA production pathway may be connected with
diminishing the risk of developing NEC inmaturing preterm
neonates.
We know that birth initiates the conversion from the
intrauterine sterile environment to the extrauterine con-
frontation with microbial and food antigens. This stimulus
has a profound effect on thematuration of mucosa associated
lymphatic tissues (e.g., Peyer’s patches) and other lymphoid
tissues [39, 40]. But surprisingly, despite themassive exposure
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to foreign antigens (dietary antigens-formula milk or breast
milk and skin-to-skin contact), enabling the colonization
with commensals earlier than in neonates from group B,
the gene expression of the intestinal immune network for
IgA production did not differ between the youngest preterm
babies from group A in their 28th DOL and children
from group B in their 5th DOL (when they reached the
same postconceptional age). It is possible that maturational
steps involved in the ontogenesis of the intestine immune
system are genetically regulated and antigen exposure does
not trigger any acceleration in their development (they are
independent from the extrinsic factors). Similar results were
obtained by Rogosch et al. [41], who confirmed that preterm
birth did not measurably accelerate thematuration of the IgA
repertoire.
5. Limitations of the Study
Our studied groups varied significantly with the percent-
age of children whose mothers received antenatal steroids.
According to the literature, prenatal use of steroids may
influence gene expression in children born preterm [42]. In
our population the rate of prenatal steroid was low, so it is
possible that in other populations where the usage of prenatal
steroids is higher, the results may be different.
The effect of congenital infection, which was present in
some of our patients, may influence gene expression.
All children included in our study were transferred from
regional hospitals and the aim of the study was to assess
the role of environmental factors occurring after birth. It
should be noted that it was not feasible to directly assess the
potential role of intrauterine factors, for example, by means
of analysis of pattern of genome expression in lymphocytes
obtained from cord blood samples. This situation might bias
our results. Unfortunately, even assessment of cord blood
samples would reflect only the very last phase of pregnancy,
directly preceding the preterm delivery, which was triggered
by various factors and not the physiological phenomena
during pregnancy.
Last but not least, it should be noted that this investigation
was performed in leukocytes, not, for example, in intestine
tissues, which raises the question of whether gene expression
of white blood cells reflects gene expression in the peripheral
tissue.However, according to some researches, around 90%of
transcripts are coexpressed in different tissues of the body, for
example, in peripheral blood mononuclear cells and skeletal
muscle cells [43].
6. Conclusion
Based on pathway enrichment analysis, we identified a
few pathways which presented a positive monotone trend
during the gestational age; most of them are involved in
host immunity. We were not able to identify any pathway
where expression of genes decreases with the gestational
age. Despite differences in gestational age, patients with the
same postconceptional age have a very similar expression of
genes. The results are of sufficient interest to warrant further
investigation on this subject.
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